Literature DB >> 1255018

Measurement of human high density lipoprotein apolipoprotein A-1 in serum by radioimmunoassay.

J B Karlin, D J Juhn, J I Starr, A M Scanu, A H Rubenstein.   

Abstract

A sensitive and specific double antibody radioimmunoassay for the major apolipoprotein (apo A-I) of human serum high density lipoprotein (HDL) was developed. Initial studies indicated that direct measurements of apo A-I concentration in whole untreated sera or isolated high density lipoprotein fractions yielded variable results, which were lower than those obtained in the corresponding samples which had been subjected to delipidation. Subsequently, it was observed that heating diluted sera or HDL for 3 hr at 52 degrees C prior to assay resulted in maximal increases in apo A-I immunoreactivity to levels comparable to those found in the delipidated specimens. This simple procedure permitted multiple sera to be assayed efficiently with full recovery of apo A-I.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1255018

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.

Authors:  G Assmann; E Smootz; K Adler; A Capurso; K Oette
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

2.  Apolipoproteins in human cerebrospinal fluid.

Authors:  P S Roheim; M Carey; T Forte; G L Vega
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Seventh-Day Adventist adolescents--life-style patterns and cardiovascular risk factors.

Authors:  R Cooper; A Allen; R Goldberg; M Trevisan; L Van Horn; K Liu; M Steinhauer; A Rubenstein; J Stamler
Journal:  West J Med       Date:  1984-03

Review 4.  [HDL cholesterol: biochemical aspects (author's transl)].

Authors:  G Assmann; H Schriewer
Journal:  Klin Wochenschr       Date:  1980-08-01

5.  Demonstration of human apolipoprotien A in isolated mucosal cells from small intestine and isolated hepatocytes.

Authors:  U Hopf; G Assmann; H E Schaefer; A Capurso
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

6.  High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.

Authors:  J R Patsch; S Prasad; A M Gotto; W Patsch
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  Isolation and characterization of cDNA clones for human apolipoprotein A-I.

Authors:  J L Breslow; D Ross; J McPherson; H Williams; D Kurnit; A L Nussbaum; S K Karathanasis; V I Zannis
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.

Authors:  M L Kashyap; L S Srivastava; C Y Chen; C G Perisutti; M Campbell; R F Lutmer; C J Glueck
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

9.  Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.

Authors:  Anny Mulya; Jeongmin Seo; Amanda L Brown; Abraham K Gebre; Elena Boudyguina; Gregory S Shelness; John S Parks
Journal:  J Lipid Res       Date:  2009-09-18       Impact factor: 5.922

10.  Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment.

Authors:  R B Goldberg; M L Reeves; D E Seigler; E A Ryan; N Miller; S L Hsia; J S Skyler
Journal:  Acta Diabetol Lat       Date:  1985 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.